Experimental work with isoxuprine for prevention of skin flap necrosis and for treatment of the failing flap.
The administration of isoxuprine intraperitoneally resulted in the complete survival of abdominal island skin flaps in rats that otherwise underwent a standard pattern of necrosis. The drug was effective when administered for two weeks before and one week after raising the flap, or when administered afterwards alone. The mechanisms of its action were investigated and are described.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D007556:Isoxsuprine / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D009336:Necrosis; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D012867:Skin / Q000473:pathology; D016038:Skin Transplantation; D014182:Transplantation, Autologous
D010643:Phenoxybenzamine; D009921:Metaproterenol; D011433:Propranolol; D007556:Isoxsuprine